340 related articles for article (PubMed ID: 25737013)
1. PRMT9 is a type II methyltransferase that methylates the splicing factor SAP145.
Yang Y; Hadjikyriacou A; Xia Z; Gayatri S; Kim D; Zurita-Lopez C; Kelly R; Guo A; Li W; Clarke SG; Bedford MT
Nat Commun; 2015 Mar; 6():6428. PubMed ID: 25737013
[TBL] [Abstract][Full Text] [Related]
2. Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2.
Hadjikyriacou A; Yang Y; Espejo A; Bedford MT; Clarke SG
J Biol Chem; 2015 Jul; 290(27):16723-43. PubMed ID: 25979344
[TBL] [Abstract][Full Text] [Related]
3. FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues.
Cook JR; Lee JH; Yang ZH; Krause CD; Herth N; Hoffmann R; Pestka S
Biochem Biophys Res Commun; 2006 Apr; 342(2):472-81. PubMed ID: 16487488
[TBL] [Abstract][Full Text] [Related]
4. Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing.
Shen L; Ma X; Wang Y; Wang Z; Zhang Y; Pham HQH; Tao X; Cui Y; Wei J; Lin D; Abeywanada T; Hardikar S; Halabelian L; Smith N; Chen T; Barsyte-Lovejoy D; Qiu S; Xing Y; Yang Y
Nat Commun; 2024 Apr; 15(1):2809. PubMed ID: 38561334
[TBL] [Abstract][Full Text] [Related]
5. Protein arginine methylation of SERBP1 by protein arginine methyltransferase 1 affects cytoplasmic/nuclear distribution.
Lee YJ; Hsieh WY; Chen LY; Li C
J Cell Biochem; 2012 Aug; 113(8):2721-8. PubMed ID: 22442049
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 Vpr interacts with spliceosomal protein SAP145 to mediate cellular pre-mRNA splicing inhibition.
Hashizume C; Kuramitsu M; Zhang X; Kurosawa T; Kamata M; Aida Y
Microbes Infect; 2007 Apr; 9(4):490-7. PubMed ID: 17347016
[TBL] [Abstract][Full Text] [Related]
7. Chemical probes for protein arginine methyltransferases.
Li ASM; Li F; Eram MS; Bolotokova A; Dela Seña CC; Vedadi M
Methods; 2020 Mar; 175():30-43. PubMed ID: 31809836
[TBL] [Abstract][Full Text] [Related]
8. SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination.
Zhao DY; Gish G; Braunschweig U; Li Y; Ni Z; Schmitges FW; Zhong G; Liu K; Li W; Moffat J; Vedadi M; Min J; Pawson TJ; Blencowe BJ; Greenblatt JF
Nature; 2016 Jan; 529(7584):48-53. PubMed ID: 26700805
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4.
Lakowski TM; Frankel A
Biochem J; 2009 Jun; 421(2):253-61. PubMed ID: 19405910
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the methyl arginines in the fragile X mental retardation protein Fmrp.
Stetler A; Winograd C; Sayegh J; Cheever A; Patton E; Zhang X; Clarke S; Ceman S
Hum Mol Genet; 2006 Jan; 15(1):87-96. PubMed ID: 16319129
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo analysis of the major type I protein arginine methyltransferase from Trypanosoma brucei.
Pelletier M; Pasternack DA; Read LK
Mol Biochem Parasitol; 2005 Dec; 144(2):206-17. PubMed ID: 16198009
[TBL] [Abstract][Full Text] [Related]
12. Methylation of Smad6 by protein arginine N-methyltransferase 1.
Inamitsu M; Itoh S; Hellman U; Ten Dijke P; Kato M
FEBS Lett; 2006 Dec; 580(28-29):6603-11. PubMed ID: 17118358
[TBL] [Abstract][Full Text] [Related]
13. Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity.
Dong H; He X; Zhang L; Chen W; Lin YC; Liu SB; Wang H; Nguyen LXT; Li M; Zhu Y; Zhao D; Ghoda L; Serody J; Vincent B; Luznik L; Gojo I; Zeidner J; Su R; Chen J; Sharma R; Pirrotte P; Wu X; Hu W; Han W; Shen B; Kuo YH; Jin J; Salhotra A; Wang J; Marcucci G; Luo YL; Li L
Nat Cancer; 2024 Apr; 5(4):601-624. PubMed ID: 38413714
[TBL] [Abstract][Full Text] [Related]
14. hCAF1, a new regulator of PRMT1-dependent arginine methylation.
Robin-Lespinasse Y; Sentis S; Kolytcheff C; Rostan MC; Corbo L; Le Romancer M
J Cell Sci; 2007 Feb; 120(Pt 4):638-47. PubMed ID: 17264152
[TBL] [Abstract][Full Text] [Related]
15. Protein Arginine Methyltransferase Product Specificity Is Mediated by Distinct Active-site Architectures.
Jain K; Warmack RA; Debler EW; Hadjikyriacou A; Stavropoulos P; Clarke SG
J Biol Chem; 2016 Aug; 291(35):18299-308. PubMed ID: 27387499
[TBL] [Abstract][Full Text] [Related]
16. The protein arginine methyltransferase PRMT9 attenuates MAVS activation through arginine methylation.
Bai X; Sui C; Liu F; Chen T; Zhang L; Zheng Y; Liu B; Gao C
Nat Commun; 2022 Aug; 13(1):5016. PubMed ID: 36028484
[TBL] [Abstract][Full Text] [Related]
17. HuD interacts with survival motor neuron protein and can rescue spinal muscular atrophy-like neuronal defects.
Hubers L; Valderrama-Carvajal H; Laframboise J; Timbers J; Sanchez G; Côté J
Hum Mol Genet; 2011 Feb; 20(3):553-79. PubMed ID: 21088113
[TBL] [Abstract][Full Text] [Related]
18. EWS is a substrate of type I protein arginine methyltransferase, PRMT8.
Kim JD; Kako K; Kakiuchi M; Park GG; Fukamizu A
Int J Mol Med; 2008 Sep; 22(3):309-15. PubMed ID: 18698489
[TBL] [Abstract][Full Text] [Related]
19. Structure and ligand binding of the extended Tudor domain of D. melanogaster Tudor-SN.
Friberg A; Corsini L; Mourão A; Sattler M
J Mol Biol; 2009 Apr; 387(4):921-34. PubMed ID: 19232356
[TBL] [Abstract][Full Text] [Related]
20. Pan-methylarginine antibody generation using PEG linked GAR motifs as antigens.
Wang Y; Person MD; Bedford MT
Methods; 2022 Apr; 200():80-86. PubMed ID: 34107353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
